Legionella Testing Market Size To Reach $547.4 Million By 2030

Legionella Testing Market Growth & Trends

The global legionella testing market size is anticipated to reach USD 547.4 million by 2030 and is expected to experience a CAGR of 8.2% from 2025 to 2030, according to a new report by Grand View Research, Inc., the increasing incidence of legionella diseases, such as Pontiac fever and pneumonia, is one of the major factors contributing to the market's growth. According to the World Health Organization (WHO), nearly 10 to 15 new cases per million population are identified every year in Europe, Australia, and the U.S.

The growing inclination towards timely legionella testing can be attributed to advantages such as speedy recovery and improved patient outcome. Additionally, integrating legionella testing methods with advanced diagnostic technologies such as PCR and point-of-care testing are expected to fuel growth of this market in the forecast period.

Government-sponsored initiatives, including legionella testing programs, awareness campaigns, and water safety regulations, are estimated to increase the detection and management of legionella cases globally. For instance, in Europe, stringent regulations mandate regular Legionella testing in water systems, which is expected to boost the demand for advanced Legionella testing methods.

 Request a free sample copy or view report summary: Legionella Testing Market Report

Legionella Testing Market Report Highlights

• Europe dominated the global legionella testing market with over 39.0% share in 2024 owing to factors such as increasing awareness regarding legionellosis, sophisticated healthcare systems, public health protection initiatives, and mandatory testing regulations in countries such as the UK and Germany.

• The IVD testing segment is expected to grow at a significant CAGR over the forecast period.

• Based on end use, the PCR segment dominated market with revenue share of 37.7% in 2024. PCR enables the precise and rapid detection of bacteria through its high sensitivity and quick turnaround time.

• Increasing legionella outbreaks recorded in numerous regions driven by factors such as demography, environmental factors and others are expected to drive demand.

• Significantly enhanced healthcare systems, growing awareness regarding timely interventions, and government initiatives associated with public health are likely to add lucrative growth opportunities to this industry over forecast period.

Legionella Testing Market Segmentation

Grand View Research has segmented the legionella testing market on the basis of type, end use, and region:

Legionella Testing Type Outlook (Revenue, USD Million, 2018 - 2030)

• Water Testing

• IVD Testing

Legionella Testing End Use Outlook (Revenue, USD Million, 2018 - 2030)

• Microbial Culture

• Direct Fluorescent Antibody (DFA) Stain

• PCR

• Others

Legionella Testing Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America

  • U.S.

  • Canada

  • Mexico

• Europe

  • Germany

  • UK

  • France

  • Italy

  • Spain

  • Denmark

  • Sweden

  • Norway

• Asia Pacific

  • Japan

  • China

  • India

  • Australia

  • South Korea

  • Thailand

• Latin America

  • Brazil

  • Argentina

• MEA

  • South Africa

  • Saudi Arabia

  • UAE

  • Kuwait

List of Key Players in Legionella Testing Market

• Abbott

• Beckman Coulter, Inc. (Danaher Corporation)

• BD

• Bio-Rad Laboratories, Inc.

• BIOMÉRIEUX

• Eiken Chemical Co., Ltd.

• Hologic, Inc.

• Pro Lab Diagnostics Inc.

• QIAGEN

• F. Hoffmann-La Roche Ltd.

• Takara Bio Inc.

• Thermo Fisher Scientific Inc.